Cardiovascular & Metabolic Disorders

USPSTF: Lifestyle Counseling Can Protect CV Health in Low-Risk Adults

USPSTF: Lifestyle Counseling Can Protect CV Health in Low-Risk Adults

A newly released recommendation statement suggests that physicians should provide lifestyle counseling to both low- and high-risk adults to prevent CVD.

Improved Aspirin Responsiveness in Obesity With Bariatric Surgery

Improved Aspirin Responsiveness in Obesity With Bariatric Surgery

Further investigation is needed to examine the mechanism behind aspirin responsiveness following bariatric surgery.

Reducing Hypoglycemia in T1D and T2D: Insulin Degludec vs Insulin Glargine

Reducing Hypoglycemia in T1D and T2D: Insulin Degludec vs Insulin Glargine

By

Compared with insulin glargine, insulin degludec significantly reduced rates of hypoglycemia in patients with either type 1 or type 2 diabetes.

Improving Patient QoL With Atorvastatin in Bronchiectasis

Improving Patient QoL With Atorvastatin in Bronchiectasis

By

High-dose atorvastatin therapy can reduce inflammation and improve quality of life in patients with severe bronchiectasis and P aeruginosa infection.

Insulin Therapy Initiation in T2D Associated With Sedentary Behavior, Weight Increases

Insulin Therapy Initiation in T2D Associated With Sedentary Behavior, Weight Increases

By

Patients with type 2 diabetes who were initiated on insulin therapy increased their sitting time and decreased their low-intensity physical activity.

Metabolic Concerns With Dutasteride Therapy for BPH

Metabolic Concerns With Dutasteride Therapy for BPH

Dutasteride therapy for benign prostatic hyperlasia has been linked to elevated HbA1c and LDL cholesterol.

Childhood Intelligence Tied to Lower Cardiovascular Mortality

Childhood Intelligence Tied to Lower Cardiovascular Mortality

By

Researchers linked all major causes of mortality to childhood intelligence.

Heart Failure in Type 2 Diabetes: Improving the Risk Model

Heart Failure in Type 2 Diabetes: Improving the Risk Model

By

N-terminal pro-B-type natriuretic peptide showed the strongest association with heart failure in patients with type 2 diabetes.

High Risk of Insulin Resistance, PTSD Biomarkers in Military Veterans

High Risk of Insulin Resistance, PTSD Biomarkers in Military Veterans

By

Eighty-three veterans with PTSD participated in a study examining biological pathways between PTSD and metabolic diseases.

Cardiometabolic Event Risk Is Adversely Affected by Chronic Inflammation

Cardiometabolic Event Risk Is Adversely Affected by Chronic Inflammation

By

The least common condition, systemic lupus erythematosus, was associated with the highest association of experiencing multiple cardiometabolic events.

Elevated Adolescent BMI Increases Stroke Risk in Adulthood

Elevated Adolescent BMI Increases Stroke Risk in Adulthood

Over 37,000 men were tracked from ages 8 to 20 to examine the link between adolescent BMI and stroke risk.

Exercise Training Intervention Improves Ventricular Function in Adolescent T1D

Exercise Training Intervention Improves Ventricular Function in Adolescent T1D

Left ventricular function can be improved, but not normalized, in adolescents with type 1 diabetes.

Two-Hour Postload Glucose Test as Predictor of Cardiovascular Events

Two-Hour Postload Glucose Test as Predictor of Cardiovascular Events

By

Two-hour postload glucose better predicted cardiovascular events compared with fasting plasma glucose and HbA1c.

Pediatric Respiratory and Atopic Outcomes With Free Sugar Consumption In Pregnancy

Pediatric Respiratory and Atopic Outcomes With Free Sugar Consumption In Pregnancy

By

Data from a UK cohort were used to examine the relationship between maternal sugar intake levels and pediatric respiratory and atopic outcomes.

Metabolic Profile, Weight Increases Assessed in  Ziprasidone Augmentation for Major Depressive Disorder

Metabolic Profile, Weight Increases Assessed in Ziprasidone Augmentation for Major Depressive Disorder

By

Escitalopram plus ziprasidone was found safe in certain patients, although the therapy required regular cardiovascular and metabolic monitoring.

Risk Factors for Preeclampsia and Pregnancy-Associated Stroke in Women

Risk Factors for Preeclampsia and Pregnancy-Associated Stroke in Women

By

Pregnancy-associated stroke risk is even higher in women with chronic hypertension, coagulopathies, and prothrombotic conditions.

Preventing Preterm Preeclampsia in At-Risk Women

Preventing Preterm Preeclampsia in At-Risk Women

Researchers examined the efficacy of aspirin in preventing preterm preeclampsia in women at risk.

Examining Health And Economic Burdens of Preeclampsia on Mothers, Children

Examining Health And Economic Burdens of Preeclampsia on Mothers, Children

Financial data for both mothers and children were examined through the first year of life.

Relationship Between Psoriasis and Cardiometabolic Comorbidities Examined

Relationship Between Psoriasis and Cardiometabolic Comorbidities Examined

By

Comorbidities included hyperlipidemia, hypertension, and type 2 diabetes, among others.

Major Adverse CV Event Prediction Via Coronary CT Angiography in T2D

Major Adverse CV Event Prediction Via Coronary CT Angiography in T2D

Extent and severity of coronary artery disease was examined in over 900 patients with type 2 diabetes.

Distinguishing Hypertension and Primary Aldosteronism Using Novel Immunoassay

Distinguishing Hypertension and Primary Aldosteronism Using Novel Immunoassay

By

Over 200 patients participated in the study of a novel immunoassay used to distinguish hypertension from hyperaldosteronism.

SGLT2 Inhibitors May Reduce Blood Pressure in Type 2 Diabetes

SGLT2 Inhibitors May Reduce Blood Pressure in Type 2 Diabetes

By

Sodium-glucose cotransporter 2 inhibitors reduced both systolic and diastolic blood pressure in patients with type 2 diabetes.

CV Event Risk Similar Regardless of Diabetes Diagnosis

CV Event Risk Similar Regardless of Diabetes Diagnosis

Statin and aspirin therapies in diabetes did not increased patients' risks of cardiovascular events.

FDA Approves Inclusion of LEADER Trial Data On Liraglutide Labeling

FDA Approves Inclusion of LEADER Trial Data On Liraglutide Labeling

By

Data from the 9300 patient LEADER trial is now eligible for inclusion on liraglutide injection packaging.

CV Risks in Juvenile Idiopathic Arthritis Tied to Serum Vitamin D Levels

CV Risks in Juvenile Idiopathic Arthritis Tied to Serum Vitamin D Levels

By

Patients with lower vitamin D levels had higher cIMT and were at elevated risk for cardiovascular conditions.

CVD Risk Management in Type 1 Diabetes Improved With Metformin

CVD Risk Management in Type 1 Diabetes Improved With Metformin

By

Although metformin did not improve glycemic control in patients with type 1 diabetes, the treatment did improve cardiovascular disease risk management.

USPSTF Updates Recommendations for Screening Obesity in Children and Adolescents

USPSTF Updates Recommendations for Screening Obesity in Children and Adolescents

By

Updates to the US Preventive Services Task Force's recommendations on obesity screening in children and adolescents focus on intensive behavioral interventions.

AHA Advisory: Replace Saturated Fat to Reduce CVD By 30%

AHA Advisory: Replace Saturated Fat to Reduce CVD By 30%

Widely promoted as healthy, coconut oil can increase LDL cholesterol levels similar to other saturated fats.

Type 2 Diabetes Death and CV Events Predicted by Systolic Blood Pressure Variability

Type 2 Diabetes Death and CV Events Predicted by Systolic Blood Pressure Variability

By

For patients with type 2 diabetes, visit-to-visit variability in systolic blood pressure may function as an independent predictor for cardiovascular events.

AHA: Promoting Self-Management in CVD Through Education

AHA: Promoting Self-Management in CVD Through Education

The most effective approaches to CVD self-management were tailored to individual patient needs and incorporated a multidisciplinary approach.

Sign Up for Free e-Newsletters